Dbv Technologies SA reports results for the quarter ended September 30 - Earnings Summary

• Dbv Technologies SA reported a quarterly adjusted loss of 70 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-1.20. The mean expectation of five analysts for the quarter was for a loss of 15 cents per share. Wall Street expected results to range from -26 cents to -11 cents per share.

• Revenue fell 42.3% to $1.60 million from a year ago; analysts expected $664.00 thousand.

• Dbv Technologies SA's reported EPS for the quarter was a loss of 70 cents​.

• Dbv Technologies SA shares had fallen by 13.9% this quarter and lost 47.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Dbv Technologies SA is $45.00, about 76.3% above its last closing price of $10.65

This summary was machine generated from LSEG data October 28 at 11:51 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)